Ab183422

antibody from Aladdin Scientific
Targeting: TNFRSF12A CD266, FN14, TweakR
Provider product page for Ab183422

Antibody data

Product number
Ab183422 - Provider product page
Provider
Aladdin Scientific
Product name
Enavatuzumab (anti-TWEAKR)
Antibody type
Recombinant
Description
Enavatuzumab (anti-TWEAKR) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab (anti-TWEAKR) induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab (anti-TWEAKR) can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab (anti-TWEAKR) inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Reactivity
Human
Conjugate
Unconjugated
Vial size
100_g,10mg,1mg,5mg
Concentration
Lot by Lot
Storage
Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
TNFRSF12A protein structure - Ab183422 shown in red.